
Symbiotec Pharmalab IPO oversubscribed 71.26 times, indicating strong investor demand.
Exploring all reports, signals, and insights archived under the #rosewood-investments treasury.

Symbiotec Pharmalab IPO oversubscribed 71.26 times, indicating strong investor demand.

Symbiotec Pharmalab IPO success, 80% subscription on opening day.